Loading company…
MabGalaxy is a Beijing biotechnology company developing antibody projects.
Founded in 2025 and based in Beijing, China, MabGalaxy is a biotechnology company developing antibody projects. In March 2026, it raised CNY 100 million in Angel funding led by Lapam Capital, with participation from Nest.Bio Labs, Yijing Investment and YuanBio Venture, to advance its pipeline and preclinical research.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in